VALA SCIENCES INC.

Company Overview

Vala Science Inc. was founded in 2004 and is headquartered in San Diego, Calif. The company develops and markets cell-image-based instrumentation, software and reagents for pharmaceutical and biotechnology scientists. It provides high-content screening service assay development and scale-up services in GLP-compliant environments. Vala Sciences offers high-content screening services for compound libraries that measure the effects of a number of target molecules. The company also develops antibodies, screening and reagent kits for imaging and biochemical applications. Its suite of reagents and screening kits include Lipid Droplet Screen-Certified Kit, Anti-perilipin 1 Antibody, Anti-p-Perilipin 1-serine 522 Antibody, Anti-p-Perilipin 1-serine 497 Antibody, Control Cell Extract, 3T3L1 Adipocytes and Forskolin-Treated Cell Extract and 3T3L1 Adipocytes. The company also provides IC class instruments, including the IC200-KIC for speed and image quality in high content screening.

The company developed KIC Arrhythmogenic Liability Screening under its toxicology testing segment. Through the screening assay, the company validated the study of more than 150 compounds. The product eliminates the false negatives and positives of single ion channel testing. Also, it provides timely analysis of hundreds of compounds per order in drug discovery. The product can accurately identify pro-arrhythmic compounds early in drug discovery. Vala Science also offers a range of fully-validated High Content Screening assays that measure lipid accumulation, adipocyte differentiation and lipid metabolism in a variety of cell types, including primary human adipocytes.

Company's Business Segments

• Precision Drug Discovery : This segment of the company includes Precision Drug Discovery with Fully Automated Analysis of hiPSC Single-Cell Kinetics.